Clinical Trials · NCT07228741
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Enrollment
- 20
- Start date
- Apr 2026
- Locations
- 1 site, United States
- Primary endpoint
- To evaluate the effectiveness for weight loss of the combined intervention using once weekly Tirzepatide plus remote, supervised, tailored resistance exercise.